Home/Filings/4/0001415889-24-010213
4//SEC Filing

DIXON WENDY L 4

Accession 0001415889-24-010213

CIK 0001701541other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 8:49 PM ET

Size

5.2 KB

Accession

0001415889-24-010213

Insider Transaction Report

Form 4
Period: 2024-03-15
Transactions
  • Award

    Common Stock

    2024-03-15$4.54/sh+3,253$14,76938,054 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 14, 2024.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001202283

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:49 PM ET
Size
5.2 KB